Treatment of exogenous obesity: use of delayed action dimethylphenethylamine
Turatti, S.; de Netto, G.A.
Revista Brasileira de Medicina 27(1): 57-63
1970
ISSN/ISBN: 0034-7264 PMID: 5517811 Document Number: 26149
Document emailed within 1 workday
Related Documents
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551Delitala, G.; Alagna, S.; Masala, A. 1977: Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity La Clinica Terapeutica 81(6): 547-554
Langlois, K.J.; Forbes, J.A.; Bell, G.W.; Grant, G.F. 1974: A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity Current Therapeutic Research 16(4): 289-296
Dabrowski, M.; Bijak, A.; Letowski, A.; Rydlewska-Sadowska, W.; RuzyłłO, W.; Hoffman, M. 1984: Treatment of hypertrophic cardiomyopathy with a delayed-action preparation of Trasicor Kardiologia Polska 27(7): 579-589
Chlud, K. 1977: Treatment of osteoporosis with a delayed-action sodium fluoride preparation Zeitschrift für Rheumatologie 36(3-4): 126-139
Spesivtseva, V.G. 1978: Exogenous, constitutional obesity Sovetskaia Meditsina 6: 27-32
Schmitt, T.; Luqman, W.; McCool, C.; Lenz, F.; Ahmad, U.; Nolan, S.; Stephan, T.; Sunder, J.H.; Danowski, T.S. 1977: Unresponsiveness to exogenous TSH in obesity International Journal of Obesity 1(2): 185-190
Landier, F.; Chaussain, J.L.; Job, J.C. 1984: Early treatment of congenital hypoplasia of the penis with intramuscular delayed-action testosterone Archives Francaises de Pediatrie 41(7): 467-471
Fireman, A.E. 1977: Obesity (exogenous) is not a medical problem Journal of the Florida Medical Association 64(9): 657-658
Losiowski, Z.; Czochañska, J.; Zimak, J. 1992: Preliminary evaluation of early results of the treatment of epilepsy in children with delayed-action carbamazepine Neurologia i Neurochirurgia Polska 26(4): 571-572
Schindler, V.H.; Bielesz, G. 1975: Treatment of iron deficiency with orally administered delayed-action ferrous sulfate and mucoproteose Wiener Medizinische Wochenschrift 125(11): 173-176
Philip-Joet, F.; Bruguerolle, B.; Parrel, M.; Vestri, R.; Arnaud, A. 1988: Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies Presse Medicale 17(5): 193-196
Fournier, D. 1981: Clinical study of delayed-action oxprenolol in the treatment of angina pectoris. Apropos of 21 cases Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 26(1-2): 62-64
Verdeau-Pailles, J. 1976: Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. a 9-month study on 55 hospitalized patients L'Encephale 2(4): 341-347
Sznajderman, M.; Niegowska, J.; Sawicki, M.; Sznajderman, M. 1987: Delayed-action nifedipine in the treatment of primary hypertension: its effect on blood pressure and serum lipids and lipoproteins Kardiologia Polska 30 Suppl: 29-37
Andreozzi, G.M.; Lepore, R. 1990: Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. a multicenter study La Clinica Terapeutica 135(4): 273-281
Brondarenko, I.M. 1978: Urine sodium and potassium in children with constitutional exogenous obesity Pediatriia 9: 42-43
Matter, M.; Cavin, R. 1993: Mason's gastroplasty for exogenous morbid obesity: results and commentaries apropos of 33 patients Revue Medicale de la Suisse Romande 113(8): 621-624
Vlasova, I.I.; Ametov, A.S. 2010: The role of hypothalomo-pituitary-adrenal system in pathogenesis of exogenous-constitutional obesity Klinicheskaia Meditsina 88(4): 48-52
Kalbarczyk, S.; Wardas, W. 1977: Therapeutic action of exogenous animal DNA Polski Tygodnik Lekarski 32(8): 335-337